buthionine sulfoximine has been researched along with carboplatin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (61.54) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, YS; Kang, JH; Kim, DJ; Kim, HK; Lee, KS; Moon, HS; Park, JG | 1 |
| de Vries, EG; Meersma, GJ; Meijer, C; Mulder, NH; Sluiter, WJ; Timmer-Bosscha, H | 1 |
| Alken, PM; Forster, S; Koessig, J; Mickisch, GH; Roehrich, K; Tschada, RK | 1 |
| Brooks, SE; Dupuis, NP; Holden, SA; Korbut, TT; Teicher, BA | 1 |
| Backes, MG; Blanock, K; Emerson, EO; Jani, JP; Rihn, C; Scalamogna, D; Singh, SV; Specht, S; Stemmler, N; Xu, BH | 1 |
| Harrap, KR; Kelland, LR; Loh, SY; Mistry, P | 1 |
| Henderson, D; Hu, BH; McFadden, SL; Salvi, RJ | 1 |
| Osmak, M; Vuković, L | 1 |
| Bennett, LC; Hale, C; Muldoon, LL; Neuwelt, EA; Purcell, SE; Walker-Rosenfeld, SL | 1 |
| Alfaro, PA; Goto, H; Kohn, DB; Pepper, KA; Petersen, D; Reynolds, CP; Yang, B | 1 |
| Aldrich-Wright, JR; Garbutcheon-Singh, KB; Harper, BW; Myers, S | 1 |
| Dvořák, Z; Kašpárková, J; Prachařová, J; Radošová-Muchová, T; Štarha, P; Trávníček, Z; Vančo, J | 1 |
| Falls, KC; Fath, MA; Klinger, AR; Rodman, SN; Ross, NL; Schoenfeld, JD; Sciegienka, SJ; Solst, SR; Spitz, DR | 1 |
13 other study(ies) available for buthionine sulfoximine and carboplatin
| Article | Year |
|---|---|
Effects of buthionine sulfoximine treatment on cellular glutathione levels and cytotoxicities of cisplatin, carboplatin and radiation in human stomach and ovarian cancer cell lines.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Buthionine Sulfoximine; Carboplatin; Cisplatin; Female; Glutathione; Humans; Methionine Sulfoximine; Ovarian Neoplasms; Radiation Tolerance; Radiation-Sensitizing Agents; Radiotherapy; Stomach Neoplasms; Tumor Cells, Cultured | 1992 |
Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds.
Topics: Antineoplastic Agents; Buthionine Sulfoximine; Carboplatin; Cisplatin; Cyclobutanes; Drug Resistance; Glutathione; Humans; Methionine Sulfoximine; Organoplatinum Compounds; Tumor Cells, Cultured | 1992 |
Mechanisms and modulation of multidrug resistance in primary human renal cell carcinoma.
Topics: Antimetabolites; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Buthionine Sulfoximine; Carboplatin; Carcinoma, Renal Cell; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Glutathione; Humans; In Vitro Techniques; Kidney Neoplasms; Membrane Glycoproteins; Methionine Sulfoximine; Neoplasm Proteins; Organoplatinum Compounds; Oxidation-Reduction; Verapamil; Vinblastine | 1990 |
Cytotoxicity of antitumor platinum complexes with L-buthionine-(R,S)-sulfoximine and/or etanidazole in human carcinoma cell lines sensitive and resistant to cisplatin.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buthionine Sulfoximine; Carboplatin; Cisplatin; Drug Resistance; Etanidazole; Female; Humans; Methionine Sulfoximine; Organoplatinum Compounds; Ovarian Neoplasms; Tumor Cells, Cultured | 1995 |
Mechanism of cross-resistance to cisplatin in a mitomycin C-resistant human bladder cancer cell line.
Topics: Antimetabolites, Antineoplastic; Biological Transport; Buthionine Sulfoximine; Cadmium; Cadmium Chloride; Carboplatin; Cell Line; Cell Survival; Chlorides; Cisplatin; Drug Resistance; Gene Expression; Glutathione; Glutathione Transferase; Humans; Isoenzymes; Kinetics; Metallothionein; Methionine Sulfoximine; Mitomycin; RNA, Messenger; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1995 |
Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Buthionine Sulfoximine; Carboplatin; Chromatography, High Pressure Liquid; Cisplatin; Culture Media; Drug Resistance; Female; Glutathione; Humans; Kinetics; Methionine Sulfoximine; Organoplatinum Compounds; Ovarian Neoplasms; Tumor Cells, Cultured | 1993 |
Intracochlear infusion of buthionine sulfoximine potentiates carboplatin ototoxicity in the chinchilla.
Topics: Animals; Antineoplastic Agents; Buthionine Sulfoximine; Carboplatin; Cell Survival; Chinchilla; Cochlea; Drug Synergism; Evoked Potentials; Hair Cells, Auditory, Inner; Inferior Colliculi; Infusion Pumps; Otoacoustic Emissions, Spontaneous; Reference Values | 1999 |
Reversal of carboplatin resistance in human laryngeal carcinoma cells.
Topics: Amphotericin B; Antineoplastic Agents; Aphidicolin; Buthionine Sulfoximine; Carboplatin; Cyclosporine; Drug Resistance, Neoplasm; Drug Synergism; Ethacrynic Acid; Humans; Laryngeal Neoplasms; Tumor Cells, Cultured | 1999 |
Rescue from enhanced alkylator-induced cell death with low molecular weight sulfur-containing chemoprotectants.
Topics: Acetylcysteine; Alkylating Agents; Antimetabolites, Antineoplastic; Apoptosis; Buthionine Sulfoximine; Carboplatin; Cell Survival; Cytoprotection; Drug Interactions; Humans; Molecular Weight; Protective Agents; Thiosulfates; Time Factors; Tumor Cells, Cultured | 2001 |
Transduction of green fluorescent protein increased oxidative stress and enhanced sensitivity to cytotoxic drugs in neuroblastoma cell lines.
Topics: Antineoplastic Agents; Apoptosis; B7-1 Antigen; Buthionine Sulfoximine; Carboplatin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Glutathione; Green Fluorescent Proteins; Humans; Lentivirus; Luminescent Proteins; Melphalan; Mutation; Neuroblastoma; Oxidative Stress; Transduction, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2003 |
Combination studies of platinum(II)-based metallointercalators with buthionine-S,R-sulfoximine, 3-bromopyruvate, cisplatin or carboplatin.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Buthionine Sulfoximine; Carboplatin; Cell Line; Cell Line, Tumor; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Synergism; Glutathione; Humans; Inhibitory Concentration 50; Molecular Structure; Neoplasms; Organoplatinum Compounds; Platinum; Pyruvates | 2014 |
Potentiating effect of UVA irradiation on anticancer activity of Carboplatin derivatives involving 7-azaindoles.
Topics: Antineoplastic Agents; Buthionine Sulfoximine; Carboplatin; Cell Line, Tumor; Cell Survival; DNA Adducts; DNA Breaks, Double-Stranded; Drug Synergism; Humans; Indoles; Molecular Structure; Neoplasms; Nucleic Acid Conformation; Proton Magnetic Resonance Spectroscopy; Spectrometry, Mass, Electrospray Ionization; Ultraviolet Rays | 2015 |
D-penicillamine combined with inhibitors of hydroperoxide metabolism enhances lung and breast cancer cell responses to radiation and carboplatin via H
Topics: Antineoplastic Combined Chemotherapy Protocols; Auranofin; Breast Neoplasms; Buthionine Sulfoximine; Carboplatin; Catalase; Cell Line, Tumor; Chelating Agents; Copper; Epithelial Cells; Female; Humans; Hydrogen Peroxide; Lung Neoplasms; Oxidative Stress; Penicillamine; Radiation; Thioredoxin-Disulfide Reductase | 2017 |